Announcement of the State Food and Drug Administration on the certification of quality management practices for non-clinical drug research (No. 4) (No. 33 of 2021)
Article Author：小益
Category：Policies & Regulations
Reading：106
In accordance with the relevant provisions of the "Pharmaceutical Administration Law of the People's Republic of China", "Pharmaceutical Non-clinical Research Quality Management Practices" (GLP) and "Pharmaceutical Non-clinical Research Quality Management Practice Certification Management Measures", the State Drug Administration organized relevant experts to report to Beijing Seven institutions including the Drug Inspection Institute (Drug Safety Evaluation Center) conducted inspections. After review, the test items such as single- and multiple-dose toxicity tests (rodents) of these 7 institutions meet the requirements of drug GLP (see appendix).
Special announcement.
Attachment: Drug GLP Certification List
National Food and Drug Administration
March 2 2021
Annex to Announcement No. 33 of 2021 of the National Medical Products Administration.doc 
